Infectious mononucleosis: What it is, symptoms, causes, diagnosis, treatment and more
Infectious mononucleosis, often called "mono," is a viral illness best known for causing extreme fatigue, sore throat and swollen glands.
Feb 2, 2026
0
0
Hemic and Lymphatic Diseases: News and Research on Lymphoproliferative Disorders
MeSH tree: C15.604.515
New therapy combination yields high remission rates in early-stage Hodgkin lymphoma
Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of therapies—brentuximab vedotin and nivolumab combined with chemotherapy drugs doxorubicin and dacarbazine—according ...
Jan 25, 2026
0
2
Young cancer survivors may face faster aging and possible early-onset dementia
Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to a new study, which also describes how accelerated aging occurs both at the cellular level and in brain function, ...
Jan 7, 2026
0
0
Molecular mechanism reveals how viral infection triggers aggressive leukemia
Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia virus type I (HTLV-1) drives the development of adult T-cell leukemia-lymphoma (ATL), one of the most ...
Jan 5, 2026
0
0
Combination therapy for Burkitt's lymphoma dramatically improves cure rates in mice
Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most often in children and young adults. In recent years, CAR-T cell therapy—often referred to as a "living ...
Jan 2, 2026
0
0
B cells temporarily regain stem-like flexibility, increasing risk of lymphoma formation
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more flexible (plastic) stem-cell-like ...
Dec 29, 2025
0
39
Giving less chemotherapy can still cure lymphoma patients in their 80s, study says
People aged 80 and older with a common type of lymphoma can take a half-dose of chemotherapy and be cured or significantly extend their survivorship with fewer toxic side effects, a new study shows.
Dec 17, 2025
0
0
New guideline maps care for pregnant women with blood cancers
A new guideline from the American Society of Clinical Oncology (ASCO) offers clear, evidence-based direction for treating blood cancers during pregnancy and shows that many patients can safely receive timely cancer care without ...
Dec 15, 2025
0
0
FDA approves expanded indication for Jaypirca
The U.S. Food and Drug Administration has approved an expanded indication for Eli Lilly's Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults with relapsed or refractory ...
Dec 10, 2025
0
0
Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when compared with bendamustine ...
Dec 9, 2025
0
0
